Fig. 1From: Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosisA N-acetylcysteine amide (NACA, NPI-001); B (2R,2R′)-3,3′-disulfanediyl bis(2-acetamidopropanamide) (diNACA, NPI-002); C cysteamineBack to article page